Linked Life Data

20079483

Source:http://linkedlifedata.com/resource/pubmed/id/20079483

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-3-1
pubmed:abstractText
1. Metformin is not efficient enough in order to regulate menstrual cycles. 2.Metformin is not efficient enough in order to treat hyperandrogenism. 3. Metformin should not be used as a first-line treatment in order to treat infertility. Clomiphene citrate (CC) is the reference treatment. 4. Metformin in addition to CC is not recommended as a second line treatment, after the failure of CC alone. 5. Metformin should not be used during pregnancy in non diabetic women with PCOS, in order to prevent the risk of gestational diabetes. 6. Metformin should be prescribed to PCOS women when they are diabetic, in order to prevent their cardiovascular risk, after lifestyle modification. 7. Metformin should not be used in PCOS non diabetic women in order to lose weight. Metformin should not be used in order to treat dyslipidemia in women with PCOS. 8. In PCOS women, without diabetes, but with fasting hyperglycemia or carbohydrate intolerance, metformin should be prescribed if: BMI>35.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0003-4266
pubmed:author
pubmed:copyrightInfo
Copyright (c) 2009. Published by Elsevier Masson SAS.
pubmed:issnType
Print
pubmed:volume
71
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
25-7
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Should physicians prescribe metformin to women with polycystic ovary syndrome PCOS?
pubmed:affiliation
Service d'endocrinologie pédiatrique, hôpital Saint-Vincent-de-Paul, 82 avenue Denfert-Rochereau, Paris, France. lise.duranteau@cch.aphp.fr
pubmed:publicationType
Journal Article, Review